ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
UroGen Pharma Ltd

UroGen Pharma Ltd (URGN)

16.37
-0.57
(-3.36%)
Closed July 24 4:00PM
16.37
0.00
( 0.00% )
Pre Market: 7:09AM

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
16.37
Bid
15.66
Ask
18.35
Volume
5
0.00 Day's Range 0.00
8.69 52 Week Range 24.13
Market Cap
Previous Close
16.37
Open
-
Last Trade
5
@
15.65
Last Trade Time
08:00:06
Financial Volume
-
VWAP
-
Average Volume (3m)
675,673
Shares Outstanding
36,130,121
Dividend Yield
-
PE Ratio
-5.78
Earnings Per Share (EPS)
-2.83
Revenue
82.71M
Net Profit
-102.24M

About UroGen Pharma Ltd

UroGen Pharma Ltd is a clinical stage biopharmaceutical company focused on developing novel therapies designed to change the standard of care for urological pathologies. The company has an innovative and broad pipeline of product candidates that can overcome the deficiencies of current treatment opt... UroGen Pharma Ltd is a clinical stage biopharmaceutical company focused on developing novel therapies designed to change the standard of care for urological pathologies. The company has an innovative and broad pipeline of product candidates that can overcome the deficiencies of current treatment options for a variety of urological conditions with a focus on uro-oncology. Its lead product candidates, UGN-101 and UGN-102, are proprietary formulations of the chemotherapy drug Mitomycin C, or MMC, a generic drug, which is used off-label for urothelial cancer treatment only in a water-based formulation as an adjuvant, or supplemental post-surgery, therapy. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
Headquarters
Ra'anana, Center, Isr
Founded
1970
UroGen Pharma Ltd is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker URGN. The last closing price for UroGen Pharma was $16.37. Over the last year, UroGen Pharma shares have traded in a share price range of $ 8.69 to $ 24.13.

UroGen Pharma currently has 36,130,121 shares outstanding. The market capitalization of UroGen Pharma is $591.45 million. UroGen Pharma has a price to earnings ratio (PE ratio) of -5.78.

URGN Latest News

UroGen Pharma Announces Pricing of Public Offering of Ordinary Shares and Pre-Funded Warrants

UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced the pricing of...

UroGen Pharma Announces Commencement of Public Offering of Ordinary Shares and Pre-Funded Warrants

PRINCETON, N.J., June 17, 2024 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and...

UroGen Announces Unprecedented 82.3% Duration of Response at 12 Months in the ENVISION Trial Investigating UGN-102 as Potentially the First FDA-Approved Non-Surgical Treatment for LG-IR-NMIBC

Kaplan-Meier Estimate of Duration of Response at 12 Months in Patients Who Achieved a Complete Response at Three Months was 82.3% (95% CI, 75.9%, 87.1%) Side Effect Profile Consistent with...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.36-2.1518230723316.7316.9515.5837044616.39825207CS
4-0.86-4.9912942542117.2318.1514.8951376116.59623945CS
121.8112.431318681314.5620.710.600167567316.19791071CS
261.117.2739187418115.2620.710.600150236516.17179645CS
527.2779.89010989019.124.138.6947545416.71361649CS
1561.167.6265614727215.2124.134.8524653814.3677795CS
260-15.41-48.489616110831.7836.724.8522271517.61555437CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
PBMPsyence Biomedical Ltd
$ 1.06
(170.82%)
27.02M
POAIPredictive Oncology Inc
$ 1.87
(74.77%)
15.05M
TIVCTivic Health Systems Inc
$ 0.485
(58.50%)
38.54M
MIRAMIRA Pharmaceuticals Inc
$ 3.5012
(48.36%)
14.08M
STSSSharps Technology Inc
$ 0.3249
(36.92%)
5.63M
TWOU2U Inc
$ 1.16
(-71.84%)
453.88k
MXLMaxLinear Inc
$ 16.30
(-26.87%)
74.08k
CMMBChemomab Therapeutics Ltd
$ 1.15
(-19.01%)
1.16M
NUZENuZee Inc
$ 2.75
(-17.91%)
447.57k
IROQIF Bancorp Inc
$ 14.44
(-16.53%)
1.42k
TIVCTivic Health Systems Inc
$ 0.485
(58.50%)
38.54M
PBMPsyence Biomedical Ltd
$ 1.06
(170.82%)
27.02M
CEROCERo Therapeutics Holdings Inc
$ 0.2499
(18.44%)
25.67M
SLNASelina Hospitality PLC
$ 0.0396
(-13.35%)
19.39M
POAIPredictive Oncology Inc
$ 1.87
(74.77%)
15.05M

Discussion

View Full Feed
Jetmek_03052 Jetmek_03052 3 minutes ago
Netlist is looking ahead to their capital requirements, in these patent fights. Yes, it's dilution. No doubt about it. But this is a clear message to Samsung, Google and Micron. NLST will not give up this fight and they have already been successful in the court room to the tune of almost a bill
NLST
jedijazz jedijazz 3 minutes ago
$CBDW New Blog out! Chatbots in Investor Relations: A New Era of Efficient Communication and How 1606 Corp (CBDW) is Leading the Way on the OTC @CBDWInc https://cbdw.ai/chatbots-in-investor-relations-a-new-era-of-efficient-communication-and-how-1606-corp-cbdw-is-leading-the-way-on-the-otc/
#
AI CBDW MSFT
samson8 samson8 3 minutes ago
Fluff news. They created an LLC is the takeaway. Thats not a major accomplishment.

Of course they had to throw in the pump statement that they are "working to integrate AI".

Trucking and logistics got hammered last year too. Theres a reason Tom Z wants to get rid of it.
GTVH
surfkast surfkast 3 minutes ago
Admitting to being a scammer and burning investors is pathetic.
GVSI
WooptdooU WooptdooU 4 minutes ago
The lebbys need to return the $MILLIONS$ in CASH they TOOK. pity, really...
MILLIONS
louieforpar louieforpar 4 minutes ago
Here are 3 minutes straight of Donald Trump confusing and forgetting people's names, the names of cities he is in and more
— MeidasTouch (@MeidasTouch) June 19, 2024




http://pic.twitter.com/OJSixOIBR9
arachnodude arachnodude 4 minutes ago
YNIGH! So, there's that!
KBLB
carolinatiger carolinatiger 5 minutes ago
Sure you do. Lol. Give it up.
IGPK
gail gail 5 minutes ago
grabbed some. i feel a run is coming.
CERO
Dr Martin VanNostrand Dr Martin VanNostrand 5 minutes ago
Big time. WOW
RONN
conix conix 5 minutes ago
Meat for the Liberal Carnivores

https://www.standard.co.uk/comment/kamala-harris-joe-biden-donald-trump-b1172627.html

www.standard.co.uk/comment/kamala-harris-joe-biden-donald-trump-b1172627.html

Kamala's secret weapon? Donald Trump himself.
PonkenPlonken PonkenPlonken 5 minutes ago
nice
STSS
stock-hunter stock-hunter 5 minutes ago
We need updates from Barry. They didn’t get current for not having a plan.
RLTR
TheFinalCD TheFinalCD 5 minutes ago
TY However, the design of the VK2735 phase-3 trials will not be finalized until after the end-of-phase-2 meeting with the FDA in 2H24, which more than likely means 4Q24.
VKTX
Triforce Triforce 6 minutes ago
NUBURU Announces Strategic Marketing Partnership with NexGenAI Solutions Group

07/25/2024

https://ir.nuburu.net/news/news-details/2024/NUBURU-Announces-Strategic-Marketing-Partnership-with-NexGenAI-Solutions-Group/default.aspx
BURUD
SSKILLZ1 SSKILLZ1 6 minutes ago
There is good news by the way. You don't have to see the yanks play anymore against the Mets. I'm gathering Cole appreciates that the most. Of course I could be completely wrong on this if the mets/Yanks face in the WS but I wouldn't be holding my breath on that. LOL.
show_me_money show_me_money 6 minutes ago
Ask changed for sure.
RONN
mikepgator mikepgator 6 minutes ago
Im talking about the overall market, if it takes a dive and takes coop with it, they could be ready to scoop up cheap shares.
COOP
Twilson Twilson 6 minutes ago
Futures starting to turn green
Louied91 Louied91 6 minutes ago
$VTAK Catheter Precision, Inc. Completes Enrollment of 75 Patients in LockeT-II Study

https://www.accesswire.com/892490/catheter-precision-inc-completes-enrollment-of-75-patients-in-locket-ii-study

FORT MILL, SC / ACCESSWIRE / July 25, 2024 / Catheter Precision, Inc. (N
VTAK
glenn1919 glenn1919 6 minutes ago
TNXP......TRNR........https://stockcharts.com/h-sc/ui?s=TRNR&p=D&yr=0&mn=2&dy=12&id=p84071410134
https://stockcharts.com/h-sc/ui?s=TNXP&p=D&yr=0&mn=2&dy=12&id=p84071410134
TNXP TRNR
powerbattles powerbattles 7 minutes ago
$STSS Loaded up .32
STSS
dukeb dukeb 7 minutes ago
Have you already replaced your Biden shirts, hats, flags, dinner plates and other paraphernalia with the Harris equivalents?

So much shopping to do!

/s

Your Recent History

Delayed Upgrade Clock